Member Info for stt1

Kaiver,
"My understanding is DiM will own the data, companies will pay a subscription/licensing fee to access the datasets they want to use."

Why haven't there been any contracts for DiM data? Why does it need to be spun off before it wins any contracts?

Money going round the subsidiaries!

Tricky
"Why would you deny the fact, there are hundreds of companies providing services under the NHS."

It's good you've now accepted that the NHS does need private companies to help run the service - a point I've made on numerous occassions when it has been suggested that the govn will cancel all private providers... ;-)

You fail to miss the point, yet again.

What competitors operate in TLY market, which is a diversified business offering an integrated Out of Hospital service across Urgent Care, Planned Care, Insourcing. There will be companies who operate in each of these segments but which competitors offer the integrated service. ie Urgent Care, Planned Care AND Insourcing??.

It's not a crowded market. Name the competitors who operate the integrated service?.

The figures over the past 4 yrs are evidence that the business continues to grow.
Increasing recurring revenues £127m+
Growing cash £15m as of 31st March, despite buying 2 companies.
Increasing profits.
Increasing dividends.
Mcap £80m

Moniman,
"Cash would not increase from last year's £15.1 million"

You completely miss the point.
What is the cash position then PIs can decide for themselves?

As you mention TLY. Again you haven't read the company newsflow. They bought 2 acquisitions from cash AND still increased their cash balance.

It helps if you read the company/sector newsflow.

Profit
"Cash on a certain date is transitory so not sure is particularly useful. What is clear is that two years after the placing, OO has less cash than it raised so is neither profitable or generating cash in any meaningful sense."

Cash balances are useful as they will show whether the company is likely to need a placing. The fact they published the cash balance in June 2021 when they published fy2020 results but omitted it this time, in TU and AGM is questionable.
I find that very odd and I see that as a red flag.

Citizen
"what is a crowded market."

Why is it a crowded market?
Look at their diversified business model and tell us what other businesses operate in their markets, all 4 UK nations and Republic of Ireland?.

Their diversified business model consists of:
1) Urgent Care - largest provider of Urgent Care Centres.
2) Planned Care - Physio, dermatology etc
3) Pioneer Health - insourcing to help reduce the millions waiting for elective operations. It is govn policy and an urgent one to reduce the backlog of operations.
4) Corporate wellbeing - new acquisition. Companies are responsible for staff well being, whether working in the office or working from home.

last 3 yrs:
period, revenue, cash, ebitda
2019 £78m, £7.5m, £1.1m
2020 £105m, £8.9m, £4m
2021 £113m, £14.8m, £5m
2022 £127.4m, £15.3m, £6.2m

Increasing recurring revenues, increasing cash, increasing profits.
Oh and increasing dividends.
;-)

Moniman,

2 earning enhancing acquisitions:

Dec 2021:
Energy Pro fit. £1m on completion.
"The Consideration will be satisfied by the payment of £1.0 million in cash on completion, satisfied using existing cash resources of the Company"
https://www.investegate.co.uk/totally-plc--tly-/rns/acquisition-of-energy-fit-pro/202112160700068175V/

7th March 2022:
Pioneer £5.52m on completion

"The initial cash Consideration payable will be satisfied using the existing cash resources of the Company"
"At completion, £5.52 million will be payable to the Vendors in cash, on a cash-free and debt-free basis"
https://ir.design-portfolio.co.uk/viewer/51/25528

So, Moniman, add £6.52m to the cash balance and you'll see how much cash they would have had without those earnings enhancing acquisitions...
What do you get, oh nearly £22m or 50% higher than fy2021...
Good cash eh..

Mcap £82m...

;-)

Monimman,
"I see the cash position hasn't grown barely at all in the past 12 months "

Read the results.

They had 2 key earnings enhancing acquisitions during the year and despite using existing cash, they STILL increased cash over the prior year. ;-)

"We have made great progress against our buy and build strategy with two key acquisitions completed in the year. The addition of Pioneer Health Care and Energy Fitness Professionals to the Group enables us to respond to challenges faced in healthcare at the current time and equips us for a changing healthcare landscape where wellbeing is higher on the agenda and waiting lists are at all-time highs."

https://ir.design-portfolio.co.uk/viewer/51/27035

Read the company/sector newsflow.

;-)

Investor Meet presentation tomorrow at 10am.

https://www.investormeetcompany.com/totally-plc/register-investor

Isn't it odd that their cash position as of 31st May 2021 is the same as in the fy2021 results, 31st December 2021???

Despite the fact last year that the cash should build up strongly by Dec 2021, which it didn't..

"The Group is very well capitalised and was strengthened through two placings in 2020 raising a combined total of £17.9m (before expenses) and strong working capital management through advanced cash payments on major agreements. As at 31 December 2020 cash and cash equivalents were £19.2m. Cash as of end May was £15.1m, reflecting the expected release of customer prepayments in H1 2021, which should build back strongly by year end as we close contracts for execution in 2022 "

https://otp.tools.investis.com/clients/uk/open_orphan/rns/regulatory-story.aspx?cid=2484&newsid=1484078

Noelpro,
"You know well that no company is going to just post its cash balance on any arbitrary day."

It's not an arbitary day, it's end of H1 2022.

Last year, fy results were published on 17th June 2021.
Yet they DID publish their cash position as of 31st May 2021, 1 month before H1 end.

So if they didn't have a problem last year, why do they have a problem this year???
Very questionable and poses the question why they hiding their cash position?.

Evidence:
From fy2020 results last year - 17th June 2021
-- Cash and cash equivalents of GBP15.1m as at 31 May 2021

https://otp.tools.investis.com/clients/uk/open_orphan/rns/regulatory-story.aspx?cid=2484&newsid=1484078

Note the fy results don't appear on their website either!!

Moniman,

It's a legitimate question about cash position.

Are you not confident about your holding here that you don't wish PIs to know the cash position?
Threads exist to discuss these important company matters, don't they?

Moniman,

So you don't know how much cash they have got as of H1?
Very questionable for the company to keep PIs in the dark, given they would know the cash position as of 30th June, 2 weeks ago.

Begs the question, are they planning a placing?

Still no date for spin offs.. Maybe sometime later this year.... Whatever happened to by end of 2021???

Still lots of jam tomorrow...

"Following a significant upgrade to forecasts in April 2022, Totally delivered preliminary results for the year ended March 2022 that were ahead of our revised expectations. This is a remarkable result given the continuing challenges affecting the healthcare market and the delivery of services. We see many opportunities for further growth over the next three years and this is reflected in our forecasts which now include projections for FY25. With macro-economic and political headwinds increasing almost daily we consider that an investment in Totally offers strong growth with significantly lower risk than many other businesses. We therefore continue to believe that a fair value of 75p is achievable over the forecast period."

"Low risk investment – We consider Totally to be a relatively low risk investment with the government being the primary customer through the NHS, an important consideration during a period of increasing financial, macro-economic and political upheavals. With another record year in prospect and c.8p per share of cash (17% of the share price) on the balance sheet, we continue to believe that fair value of 75p is achievable.

https://www.allenbycapital.com/our-research/?fwp_research_client=440

"Committed with them to bring forward the financials, Sept interims where will show the market the cash balance etc"

Given H1 ended 2 weeks ago, they would know the cash position as of H1 end.
It's questionable that they still refusing to state how much cash they have.

"one of the very few AIM companies that will never fundraise again "

That's a stupid statement to make.
Never say never as it will come back and bite.

fy2020 they had £19m, fy2021 they had £15m.
So clearly cash was reducing.

So how much cash do they have as of end H1 2022, June 2022?

The rest of AGM comments are mostly jam tomorrow. Still no spin offs.

NHS Wales:
Patients waiting 2yrs at record high.

NHS Wales waiting times: Two years growth and new record

https://www.bbc.co.uk/news/uk-wales-61908285

TLY provides it's services in all 4 UK nations and Republic of Ireland.

Steveo
"Going back to my original comment, I track a number of other healthcare/biotech related stocks:"

So you're referring to covid shares, which have been pumped and then dumped as the country moves towards 'living with covid'.

The highs were around April 2021 and not end of summer 2021.
so soon after the outcomes of the 1st jabs. So it was becoming common knowledge that vaccines are going to work.

The covid boom and bust reminds me of the .com boom and bust.

Everyone (inc every reader here) needs healthcare, covid or not.

In terms of TLY, I'm comparing the revenues, which posters like to pump OO stating the revenue v mcap. I'm comparing dividends and BoD credibility.

OO is jam tomorrow with questionable corporate structure, failed Polb spin off, postponed further spin offs and doubts over the cash position and credibility issues with statements made by BoD.
With TLY, the future's bright with govn moving towards the need to tackle backlog of operations, better cash position, higher recurring revenues, paying dividends all for a lower mcap..

Steveo,
" I think you'd struggle to find an AIM health/biotech that has performed well since the end of summer 2021."

I wouldn't struggle...
OO hasn't performed well since before summer 2021, hasn't it? In fact since April 2021 when the sp was around 42p, it has on a downtrend.

On the other hand, AIM Health company TLY has performed well and given the shift to tackling backlog of operations, I believe there's more to come.

TLY
fy results are March 31st.
fy2021 31p
fy2022 35p

So April 2021 to April 2022 the sp increased from around 30p to around 49p, a huge 60% increase. In the same period OO went from 42p to 15p, a huge drop of 60%..

TLY has a lower Mcap than OO but makes increasing recurring revenues of £122m compared to OO's £50m..
TLY has £15m cash, as of 31st March (latest TU for fy2022) whereas OO won't say how much cash they have as of latest results.

Plus TLY pays a dividend.

TLY Results due next month.

The govn's policy has shifted to tackling the huge backlog of operations, GP/A&E waiting times.
TLY's diversified business model operates in 4 UK nations plus Republic of Ireland.

https://www.totallyplc.com/our-services/

Mcap only £76m with £15m cash and £122m revenues.

"Mo the new CEO with the full support of CF is doing a great job of winning new contracts with top 10 pharmaceutical companies, nearly £50 million signed since mid October"
Mo became CEO only 3 months ago and those contracts would have been in the pipeline for months, so those contracts weren't because of Mo. How well Mo is performing won't be known for months, possibly a year.

Also since same Oct there's been missed deadlines, complete mess of Polb, promised spin offs not happening etc
The £50m contracts v £90m mcap!!!

From the results:
Which entity do you shareholders have shares in? It's not the parent company which made a £1.5m loss, is it?
Where's the income statement account for the parent company?

"The Company has elected to take the exemption under section 408 of the Companies Act 2006 not to present the parent Company income statement account. The loss for the parent Company for the year was £1,522,000 (2020: loss of £1,891,000)."

https://otp.tools.investis.com/clients/uk/open_orphan/rns/regulatory-story.aspx?cid=2484&newsid=1591538

shandy
"Quoting a cash position on a single day can be slightly misleading, "

No it's not. Stating the current cash position at the time of the publication of the results or the end of the month before, ie 31st May 2022, would be quite normal. Not stating it raises more questions.